In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial | Zendy

Rain Jögi | Zendy; Satu Lähelmä | Zendy; Mikko Vahteristo | Zendy; Anita Happonen | Zendy; Jussi Haikarainen | Zendy

Open Access

In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial

Author(s) -

Rain Jögi,

Satu Lähelmä,

Mikko Vahteristo,

Anita Happonen,

Jussi Haikarainen

Publication year - 2018

Publication title -

journal of aerosol medicine and pulmonary drug delivery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.678

H-Index - 68

eISSN - 1941-2703

pISSN - 1941-2711

DOI - 10.1089/jamp.2018.1463

Subject(s) - fluticasone propionate , medicine , fluticasone , salmeterol , asthma , copd , percentile , inhaler , randomized controlled trial , dry powder inhaler , budesonide , anesthesia , mathematics , statistics

The Easyhaler ® device-metered dry powder inhaler containing Salmeterol and Fluticasone propionate (S/F) has been developed for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD). We report two studies which evaluated the in vitro flow rate dependence of delivered dose (DD) and fine particle dose (FPD) of S/F Easyhaler versus Seretide Diskus ® .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research